159 related articles for article (PubMed ID: 6780255)
21. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
Fu Y; Nathan DM; Li F; Li X; Faustman DL
J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
[TBL] [Abstract][Full Text] [Related]
22. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
23. Endothelin-1 levels in patients with disorders of the thyroid gland.
Tilly N; Schneider JG; Leidig-Bruckner G; Sommer U; Kasperk C
Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):80-4. PubMed ID: 12746758
[TBL] [Abstract][Full Text] [Related]
24. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin allotypes and RFLPs in disease association.
Propert D
Exp Clin Immunogenet; 1995; 12(3):198-205. PubMed ID: 8534506
[TBL] [Abstract][Full Text] [Related]
26. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis.
Prahalad S; Shear ES; Thompson SD; Giannini EH; Glass DN
Arthritis Rheum; 2002 Jul; 46(7):1851-6. PubMed ID: 12124869
[TBL] [Abstract][Full Text] [Related]
27. IgG heavy-chain (Gm) allotypes and HLA-antigens in insulin-dependent diabetes mellitus in Korea.
Okimoto K; Nakao Y; Matsumoto H; Min HK; Kim EJ; Lee TH; Yoon JS; Higa S; Oura T; Mimura G
Tohoku J Exp Med; 1983 Dec; 141 Suppl():283-7. PubMed ID: 6440310
[TBL] [Abstract][Full Text] [Related]
28. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin constant heavy G chain genes as risk factors in childhood allergies.
Oxelius VA; Bråbäck L; Ahlstedt S; Björkstén B
Clin Exp Allergy; 2006 Dec; 36(12):1616-24. PubMed ID: 17177686
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study.
Yu O; Bohlke K; Hanson CA; Delaney K; Rees TG; Zavitkovsky A; Ray P; Mullooly J; Black SB; Benson P; Thompson WW; Davis RL; Jackson LA
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):736-45. PubMed ID: 17192842
[TBL] [Abstract][Full Text] [Related]
31. Serum Gm allotype levels in common variable immunodeficiency: preponderance of homozygous G2m(",") on IGHCG2.
Oxelius VA; Ochs HD
Exp Clin Immunogenet; 1996; 13(2):70-7. PubMed ID: 9063698
[TBL] [Abstract][Full Text] [Related]
32. Gm and Km allotypes in four Sardinian population samples.
Walter H; Matsumoto H; De Stefano GF
Am J Phys Anthropol; 1991 Sep; 86(1):45-50. PubMed ID: 1951660
[TBL] [Abstract][Full Text] [Related]
33. Genetic variation at the immunoglobulin allotype loci in Creoles of Trinidad.
McGowan VM; Reed TE; Schanfield MS; Goliah S; Poon-King T
Am J Phys Anthropol; 1990 Apr; 81(4):555-62. PubMed ID: 2333942
[TBL] [Abstract][Full Text] [Related]
34. Gm allotype associated resistance and susceptibility to alopecia areata.
Galbraith GM; Thiers BH; Pandey JP
Clin Exp Immunol; 1984 Apr; 56(1):149-52. PubMed ID: 6424985
[TBL] [Abstract][Full Text] [Related]
35. Gm and Inv allotypes in premature infants.
Daveau M; Rivat L; Ropartz C; Fessard C
Biomedicine; 1975 Feb; 23(1):23-7. PubMed ID: 1174635
[TBL] [Abstract][Full Text] [Related]
36. IgG heavy-chain (Gm) allotypes in familial polyposis coli.
Pandey JP; Ebbesen P; Bülow S; Svendsen LB; Fudenberg HH
Am J Hum Genet; 1986 Jul; 39(1):133-6. PubMed ID: 3092642
[TBL] [Abstract][Full Text] [Related]
37. Gm allotypes in Swedish myasthenia gravis patients.
Smith CI; Grubb R; Hammarström L; Matell G
J Immunogenet; 1983 Feb; 10(1):1-9. PubMed ID: 6601678
[TBL] [Abstract][Full Text] [Related]
38. [Thyropathies and Gm markers of heavy-chain serum immunoglobulins].
Felt V; Herzog P; Majský A; Vavrejnová V; Nedvídková J; Strasek J
Vnitr Lek; 1985 Oct; 31(10):974-9. PubMed ID: 3937327
[No Abstract] [Full Text] [Related]
39. Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.
Gaiser CN; Johnson MJ; de Lange G; Rassenti L; Cavalli-Sforza LL; Steinman L
J Clin Invest; 1987 Jan; 79(1):309-13. PubMed ID: 2878940
[TBL] [Abstract][Full Text] [Related]
40. Autoimmunity in vitiligo: relationship with HLA, Gm and Km polymorphisms.
Lorini R; Orecchia G; Martinetti M; Dugoujon JM; Cuccia M
Autoimmunity; 1992; 11(4):255-60. PubMed ID: 1581470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
